Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval
Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite potential risks. Read more on BMY here.
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” the Food and Drug Administration said.
Business Wire
13h
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
health.wusf.usf.edu
12h
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Hezbollah leader killed
Helene: How to help
Human rabies death in MN
Houthis attack US warships
121st loss of the season
NC dam failure ‘imminent’
Congressional Gold Medal
Dow closes at record high
Haney sues Garcia
Van Gogh paintings attacked
High-end brothel plea
ICE: Convicts roaming free
'Harry Potter' star dies
NY ballot appeal rejected
Troops to leave some bases
Meta hit with privacy fine
Deposition in AI suit
Diocese reaches settlement
Bill to use birth control
KY sues Express Scripts
Fed inflation gauge cools
Promotes watch collection
US charges three Iranians
ISR targets Hezbollah HQ
Ending password-sharing
Pleads not guilty
Fake Biden robocalls fine
Producing doc on Diddy
Killer gets life sentence
Feedback